Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07148258 · ClinicalTrials.gov registry record · NA

Evaluating Georgia Part C Implementation Outcomes

A NA study of Autism and Communication Disorder, Childhood, sponsored by Emory University.

Recruiting
Registry status
NA
Development phase
80
Enrollment target
1
Study location

NCT07148258: Recruiting NA study of Autism and Communication Disorder, Childhood, sponsored by Emory University.

NCT07148258 is a NA study of Autism and Communication Disorder, Childhood that is actively recruiting participants, run by Emory University. The registered enrollment target is 80 participants, below the 183-participant average among 104 other Autism trials with a reported enrollment target (56% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07148258, a NA study of Autism and Communication Disorder, Childhood, is actively recruiting participants, sponsored by Emory University.

RECRUITING
Registry status
NA
Development phase
80 participants
Enrollment target
1
Study location

Study Summary

This study aims to answer the question: What is the best way to help Early Intervention (EI) providers deliver high-quality services to children with communication delays for autism? The primary goal of this project is to examine the outcomes associated with delivering Project ImPACT, an evidence-based autism intervention that is delivered as part of routine training within Georgia's EI system. Providers in the study will receive one of two Project ImPACT training models to help us understand which training model helps providers learn Project ImPACT better. Specifically, this study will examine the: 1) the process and quality by which Project ImPACT is implemented and adapted by EI providers across the two training conditions; 2) factors that impact how well Project ImPACT is implemented; and 3) the child (i.e., social communication) and family (i.e., parent empowerment and fidelity) outcomes associated with receiving Project ImPACT.

Primary Outcome

Providers' Project ImPACT therapy sessions will be video recorded and will be scored retrospectively for use of core Project ImPACT strategies. The research team will measure the project fidelity by watching recorded videos of the sessions, which will allow the team to capture how effectively the adult implements a strategy. This will be scored using the Project ImPACT fidelity checklist. Provider fidelity for each intervention strategy will be rated by a trained coder using a 5-point Likert sca

Interventions

  • OTHER Project ImPACT Training As Usual
  • OTHER Project ImPACT Training Plus Co-Production
  • BEHAVIORAL Routine Project ImPACT

Study Locations (1)

Georgia

  • Marcus Autism Center - Atlanta

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2025-09-03
Est. Completion 2028-09
Phase NA
Emory University

1,208 total trials

What NCT07148258 shows while recruiting

NCT07148258 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 183-participant average among 104 other Autism trials with a reported enrollment target (56% lower).

The record links to 2 conditions, with Autism appearing as the primary indexed condition, and to 3 interventions - of which Project ImPACT Training As Usual is the first listed.

NCT07148258 reports a single indexed study location in Georgia.

Frequently Asked Questions

What is clinical trial NCT07148258 about?

NCT07148258 is a clinical study titled "Evaluating Georgia Part C Implementation Outcomes". This study aims to answer the question: What is the best way to help Early Intervention (EI) providers deliver high-quality services to children with communication delays for autism? The primary goal of this project is to examine the outcomes associated with delivering Project ImPACT, an evidence-b...

What is the current status of trial NCT07148258?

This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2025-09-03. Estimated completion is 2028-09.

What conditions does trial NCT07148258 study?

This clinical trial studies the following conditions: Autism, Communication Disorder, Childhood.

What interventions are being tested in trial NCT07148258?

The interventions under investigation include: Project ImPACT Training As Usual (OTHER), Project ImPACT Training Plus Co-Production (OTHER), Routine Project ImPACT (BEHAVIORAL).

Who is sponsoring clinical trial NCT07148258?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07148258 being conducted?

This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Autism

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07148258's enrollment target sits among peer trials

80 44th of 104 higher than 58 of 104 other Autism trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Autism trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01243931 · 80 participants · NA

    Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy

  • NCT01659203 · 80 participants · Phase 1

    Proton or Photon RT for Retroperitoneal Sarcomas

  • NCT01803451 · 80 participants · Early Phase 1

    Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass

  • NCT01964859 · 80 participants · Phase 2

    Feasibility Study for Fibroblast Autologous Skin Grafts

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07148258, the US trial registry maintained by the National Library of Medicine. NCT07148258 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.